|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10763 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-phospho-PAK1/2/3(Thr423) |
| 克隆性 | |
| 靶點(diǎn) | 詳見說(shuō)明書 |
| 適應(yīng)物種 | 詳見說(shuō)明書 |
| 形態(tài) | 詳見說(shuō)明書 |
| 宿主 | 詳見說(shuō)明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說(shuō)明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PAK1 around the phosphorylation site of (Thr423) |
抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：
1. 磷酸化p21激活激酶1/2/3抗體品牌 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；
2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來(lái)篩選最適條件；
3.用NHSB量過(guò)量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；
4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等；
5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性；
6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及*基,也可與糖基共價(jià)結(jié)合；
7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用；
8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。
產(chǎn)品訂購(gòu)信息：
英文名稱 Anti-phospho-PAK1/2/3(Thr423)
中文名稱 磷酸化p21激活激酶1/2/3抗體品牌
別 名 phospho-PAK1(pSer144)+Anti-phospho-PAK2(pSer141)+Anti-phospho-PAK3(pSer139); Alpha PAK; Beta PAK; Gamma PAK; Oligophrenin 3; OPHN3; p21 activated kinase 1; p21 Activated Kinase 1 + 2 + 3; p21 activated kinase 2 ; p21 activated kinase 3; P65 PAK; PAK1; PAK2; PAK3; PAK3beta; PAK65; PAKalpha; PAKgamma; S6/H4 kinase; Serine/threonine protein kinase PAK 1; Serine/threonine protein kinase PAK 2; Serine/threonine protein kinase PAK 3; Serine/threonine protein kinase PAK1; Serine/threonine protein kinase PAK2; Serine/threonine protein kinase PAK3; PAK1_HUMAN; PAK2_HUMAN; PAK3_HUMAN.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 細(xì)胞凋亡 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 60kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PAK1 around the phosphorylation site of (Thr423)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化p21激活激酶1/2/3抗體品牌 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell.
P21-activated kinase (PAK) is actually a family of serine/threonine protein kinases, members of which are activated by small molecular weight GTPases. The three most common isoforms are PAK 1, PAK 2, and PAK 3 (also known as alpha PAK, gamma PAK, and beta PAK, respectively). These kinases contain numerous regulatory elements that trigger diverse signaling processes such as those initiated by activated GTPases, interaction with Src homology 3 (SH3) domains, and caspase mediated proteolytic cleavage. Autophosphorylation of serine 141 (serine 144 for PAK 1 and serine 139 PAK 3), catalyzed by Cdc42, is required for activation of PAK.
Function : The activated kinase acts on a variety of targets. Likely to be the GTPase effector that links the Rho-related GTPases to the JNK MAP kinase pathway. Activated by CDC42 and RAC1. Involved in dissolution of stress fibers and reorganization of focal complexes. Involved in regulation of microtubule biogenesis through phosphorylation of TBCB. DVL1 and PAK1 form a ternary complex with MUSK which is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ). Activity is inhibited in cells undergoing apoptosis, potentially due to binding of CDC2L1 and CDC2L2. Phosphorylates MYL9/MLC2. Phosphorylates RAF1 at 'Ser-338' and 'Ser-339' resulting in: activation of RAF1, stimulation of RAF1 translocation to mitochondria, phosphorylation of BAD by RAF1, and RAF1 binding to BCL2.
Subunit : Homodimer in its autoinhibited state. Active as monomer. Interacts tightly with GTP-bound but not GDP-bound CDC42/P21 and RAC1. Binds to the caspase-cleaved p110 isoform of CDC2L1 and CDC2L2, p110C, but not the full-length proteins. Component of cytoplasmic complexes, which also contain PXN, ARHGEF6 and GIT1. Interacts with ARHGEF7. Also interacts with CRIPAK. Interacts with NISCH. Interacts with DVL1; mediates the formation of a DVL1, MUSK and PAK1 ternary complex involved in AChR clustering. Probably found in a ternary complex composed of DSCAM, PAK1 and RAC1. Interacts with DSCAM (via cytoplasmic domain); the interaction is direct and enhanced in presence of RAC1. Interacts with SCRIB. Interacts with PDPK1. Interacts (via kinase domain) with RAF1. Interaction with NCK1 and NCK2.
Post-translational modifications : Autophosphorylated when activated by CDC42/p21 and RAC1. Phosphorylation at Thr-423 by PDPK1 results in its activation.
Similarity : Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.
Contains 1 CRIB domain.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q13153.2
PAK1-3蛋白具有廣泛的生物學(xué)功能,也是一個(gè)保守的絲氨酸/蘇氨酸蛋白激酶,參與許多重要的細(xì)胞活動(dòng)。包括細(xì)胞骨架的動(dòng)力學(xué)調(diào)節(jié),細(xì)胞移動(dòng),生存和凋亡,細(xì)胞周期,基因轉(zhuǎn)錄調(diào)節(jié),細(xì)胞生長(zhǎng)信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)化等。
抗體的鑒定：
1）磷酸化p21激活激酶1/2/3抗體品牌 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來(lái)鑒定。
2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力。抗體的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來(lái)表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無(wú)窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。
3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。
Anti-Phospho-C/EBPalpha (Ser21) /FITC 熒光素標(biāo)記兔抗人、大、小鼠磷酸化轉(zhuǎn)錄調(diào)節(jié)因子C/EBP α 抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-IL-17C/FITC 熒光素標(biāo)記白介素-17C抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh CD158e NK細(xì)胞抑制性受體3DL1抗體 規(guī)格 0.2ml
LN (laminin) 層粘連蛋白(多肽抗原) 0.5mg
IGF2BP1 英文名稱： 樣生長(zhǎng)因子ⅡmRNA結(jié)合蛋白1抗體 0.2ml
Rhesus antibody Rh SSEA3 階段特異性胚胎表面抗原-3抗體 規(guī)格 0.1ml
Anti-IL-17C/FITC 熒光素標(biāo)記白介素-17C抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-IL-17(Interleukin-17)human/FITC 熒光素標(biāo)記白介素-17抗體(人)IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Phospho-Rad17 (Ser645) /FITC 熒光素標(biāo)記磷酸化細(xì)胞周期檢控Rad17蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh APE/Girdin 肌動(dòng)蛋白結(jié)合蛋白Girdin抗體 規(guī)格 0.1ml
Rabbit Anti-rat IgG/Alexa Fluor 647 Alexa Fluor 647標(biāo)記的兔抗大鼠IgG 0.1ml
GIMAP7 英文名稱： GTP酶IMAP家族成員7抗體 0.2ml
Rhesus antibody Rh Rabbit Anti-human IgM/PE-Cy3 PE-Cy3標(biāo)記的兔抗人IgM 規(guī)格 0.1ml
Anti-Phospho-Rad17 (Ser645) /FITC 熒光素標(biāo)記磷酸化細(xì)胞周期檢控Rad17蛋白抗體IgGMulti-class antibodies規(guī)格： 0.2ml
TrxR(Mouse thioredoxin reductase) ELISA Kit 小鼠硫氧還蛋白還原酶Multi-class antibodies規(guī)格： 48T
Anti-CBL2 /FITC 熒光素標(biāo)記兔抗人、大、小鼠原癌蛋白CBL2抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Egr1 早期生長(zhǎng)應(yīng)答蛋白1抗體 規(guī)格 0.1ml
CR2/sCD21(Human Soluble Cluster of differentiation 21) ELISA Kit 人可溶性CD21 96T
Phospho-MYL(Ser19) 英文名稱： 磷酸化肌球蛋白輕鏈2抗體 0.1ml
AF10 英文名稱： 髓系、淋巴、混合系易位基因10抗體 0.1ml
Anti-CBL2 /FITC 熒光素標(biāo)記兔抗人、大、小鼠原癌蛋白CBL2抗體IgGMulti-class antibodies規(guī)格： 0.2ml
C6, 大鼠腦細(xì)胞
FCGRT & B2M Others Mouse 小鼠 FCGRT & B2M Heterodimer 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
大鼠腦內(nèi)皮細(xì)胞完全培養(yǎng)基 100mL
LLC-PK1豬腎近曲小管上皮細(xì)胞 LLC-PK1 porcine kidney proximal tubular epithelial cells M199+3% FBS/DMEM+F12+12%FBS
IFNB1 Protein Mouse 重組小鼠 IFNB1 / IFN-beta / Ierferon beta 蛋白 (Fc 標(biāo)簽)
MDA-MB-468-06(人癌細(xì)胞) 5×106cells/瓶×2 Y1(腎上腺皮質(zhì)細(xì)胞)
C57小鼠瘤株;ME (Me)
OLR1 Others Human 人 OLR1 / LOX1 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
CaEs-17 人細(xì)胞
GBC-SD人細(xì)胞 GBC-SD cells in human gallbladder carcinomas RPMI-1640(GIBCO)+10%FBS
LEFTY2 Protein Human 重組人 Lefty2 / Lefty A 蛋白 (Fc 標(biāo)簽)
人肝內(nèi)膽管上皮細(xì)胞 (HIBEC)( 5×105 ) HSC-T6, 大鼠肝星狀細(xì)胞系 Rattus
磷酸化p21激活激酶1/2/3抗體品牌 MAPKAPK5 Others Human 人 MAPKAPK5 桿狀病毒-昆蟲細(xì)胞裂解液 (陽(yáng)性對(duì)照)
敘利亞倉(cāng)鼠肌肉細(xì)胞;GH-M1
CL-0081F81(貓腎細(xì)胞)5×106cells/瓶×2
KM3, 人細(xì)胞 細(xì)胞,HCC-9204細(xì)胞 NCI-H292(細(xì)胞(淋巴結(jié)轉(zhuǎn)移))
小鼠細(xì)胞;GT1-1
CD2 Others Human 人 CD2 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
|
|
|
|
|
